The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL) Meeting Abstract
| Authors: | Horwitz, S. M.; Soto, J.; Youssoufian, H.; Lloyd, D.; Le, N. T. |
| Abstract Title: | The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 422s |
| Language: | English |
| ACCESSION: | WOS:000442916007725 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS7590 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS7590 -- Source: Wos |
